Acute Leukemias - Republican Scientific Medical Library

76 Chapter 4 · Relapsed and Refractory Acute Myeloid Leukemia
sidual disease assessment by reverse-transcription polymerase
chain reaction of the PML/RAR alpha fusion gene. Blood
90(3):1321–1325
127. de Botton S, Fawaz A, Chevret S, et al. (2005) Autologous and
allogeneic stem-cell transplantation as salvage treatment of
acute promyelocytic leukemia initially treated with all-trans-retinoic
acid: A retrospective analysis of the European acute promyelocytic
leukemia group. J Clin Oncol 23(1):120–126
128. Sanz M, Arcese W, de la Rubia J, et al. (2000) Stem cell transplantation
(SCT) for acute promyelocytic leukemia (APL) in the ATRA
era: A survey of the European. Blood and Marrow Transplantation
Group (EBMT). Blood 96:2246 (abstr)
129. Guglielmi C, Martelli MP, Diverio D, et al. (1998) Immunophenotype
of adult and childhood acute promyelocytic leukaemia:
Correlation with morphology, type of PML gene breakpoint
and clinical outcome. A cooperative Italian study on 196 cases.
Br J Haematol 102(4):1035–1041
130. Paietta E (2003) Expression of cell-surface antigens in acute promyelocytic
leukaemia. Best Pract Res Clin Haematol 16(3):369–
385
131. Paietta E, Andersen J, Gallagher R, et al. (1994) The immunophenotype
of acute promyelocytic leukemia (APL): An ECOG study.
Leukemia 8(7):1108–1112
132. Bernard J, Weil M, Boiron M, et al. (1973) Acute promyelocytic
leukemia: Results of treatment by daunorubicin. Blood 41(4):
489–496
133. Petti MC, Pinazzi MB, Diverio D, et al. (2001) Prolonged molecular
remission in advanced acute promyelocytic leukaemia after
treatment with gemtuzumab ozogamicin (Mylotarg CMA-676).
Br J Haematol 115(1):63–65
134. Liso V, Specchia G, Pogliani EM, et al. (1998) Extramedullary involvement
in patients with acute promyelocytic leukemia: A report
of seven cases. Cancer 83(8):1522–1528
135. Byrd JC, Edenfield WJ, Shields DJ, et al. (1995) Extramedullary
myeloid cell tumors in acute nonlymphocytic leukemia: A clinical
review. J Clin Oncol 13(7):1800–1816
136. Evans GD, Grimwade DJ (1999) Extramedullary disease in acute
promyelocytic leukemia. Leuk Lymphoma 33(3–4):219–229
137. Hickstein DD, Hickey MJ, Collins SJ (1988) Transcriptional regulation
of the leukocyte adherence protein beta subunit during human
myeloid cell differentiation. J Biol Chem 263(27):13863–
13867
138. Ravandi F, Cortes J, Estrov Z, et al. (2002) CD56 expression predicts
occurrence of CNS disease in acute lymphoblastic leukemia.
Leuk Res 26(7):643–649
139. Specchia G, Lo Coco F, Vignetti M, et al. (2001) Extramedullary
involvement at relapse in acute promyelocytic leukemia patients
treated or not with all-trans retinoic acid: A report by the Gruppo
Italiano Malattie Ematologiche dell’Adulto. J Clin Oncol
19(20):4023–4028
140. Breccia M, Petti MC, Testi AM, et al. (2002) Ear involvement in
acute promyelocytic leukemia at relapse: A disease-associated
“sanctuary“? Leukemia 16(6):1127–1130
141. de Botton S, Sanz MA, Chevret S, et al. (2006) Extramedullary relapse
in acute promyelocytic leukemia treated with all-trans retinoic
acid and chemotherapy. Leukemia 20(1):35–41
142. Lengfelder E, Reichert A, Schoch C, et al. (2000) Double induction
strategy including high dose cytarabine in combination with alltrans
retinoic acid: Effects in patients with newly diagnosed
acute promyelocytic leukemia. German AML Cooperative Group.
Leukemia 14(8):1362–1370
143. Lo Coco F, Avvisati G, Vignetti M, et al. (2004) Front-line treatment
of acuate promyelocytic leukemia with aIDA induction followed
by risk-adapted consolidation: Results of the AIDA-2000
trial of the Italian GIMEMA Group. Blood 104(11):115a
144. Buccisano F, Maurillo L, Gattei V, et al. (2006) The kinetics of reduction
of minimal residual disease impacts on duration of response
and survival of patients with acute myeloid leukemia.
Leukemia 20:1783–1789
145. Del Poeta G, Venditti A, Del Principe MI, et al. (2003) Amount of
spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome
in acute myeloid leukemia (AML). Blood 101(6):2125–2131
146. Wilson CS, Davidson GS, Martin SB, et al. (2006) Gene expression
profiling of adult acute myeloid leukemia identifies novel biologic
clusters for risk classification and outcome prediction. Blood
108(2):685–696